Imagen Network (IMAGE) Enhances Peer Discovery with Grok-Driven Personalization Engines 
Nicolas Law Group Announces the Publication of a Report on Increasing DUI Arrests in Illinois in 2024 
JAR Audio Rebrands to JAR Podcast Solutions to Reflect Marketers’ Focus on ROI-Driven Branded Podcasts 
Steam22 Launches $STM Token, Surpasses $2M Market Cap on Day One as Blockchain-Powered Sportsbook Gains Momentum 
The 10 Best Online Courses For IT Professionals – Practical, Certified, And Worth Your Time Assertio Announces $5.0 Million Insurance Settlement and General Corporate Updates
LAKE FOREST, Ill., Feb. 03, 2021 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
BOSTON, Feb. 03, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company…
Codexis Appoints Dr. Esther Martinborough to its Board of Directors
REDWOOD CITY, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading enzyme…
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
LEXINGTON, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) — Translate Bio (Nasdaq: TBIO), a clinical-stage messenger…
Red Light Holland Announces Increase in Bought Deal Equity Financing to $10 Million
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED…
Medexus Announces Upsize to Previously Announced Bought Deal Public Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED…
Yield10 Bioscience Announces Closing of $12.7 Million Public Offering
WOBURN, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural…
Generex Biotechnology Announces Call-in Details and Agenda for Shareholder Conference Call on Friday February 5, 2021 at 9:00 AM
The access information for the investor conference call is as follows: Domestic US/Canada – 1-(866)…
Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan
Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan ATMPs are uniquely positioned to…
Skye Bioscience to Participate in Investment Conferences in February
San Diego, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE”…
Telo Genomics Retains Former Abbott & Siemens Veteran Gregg Mayer to Lead the Development of the Company’s Industry Partnership Strategy
TORONTO, Feb. 03, 2021 (GLOBE NEWSWIRE) — Telo Genomics Corp. (TSX-V: TELO) (the “Company” or…
PDS Biotech Announces Preliminary Efficacy Achievement in Phase 2 Combination Trial of PDS0101 Led by the National Cancer Institute
Full enrollment triggered by observation of 3 objective responses in continued evaluation of the initial…
AXIM® Biotechnologies Begins Clinical Trials on Its ImmunoPass Rapid Diagnostic Test With Vaccine Recipients
SAN DIEGO, Feb. 03, 2021 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,”…
Marrone Bio Innovations Issues Shareholder Letter
DAVIS, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone…
UPDATE – CytomX Therapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
SOUTH SAN FRANCISCO, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage,…
Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate
Study reached primary and secondary endpoints of safety and immunogenicity, respectively VXA-CoV2-1 induced potent CD8+…
Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin
NEW YORK, NY, Feb. 03, 2021 (GLOBE NEWSWIRE) — Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or…
electroCore to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
ROCKAWAY, N.J., Feb. 03, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine…
Aligos Therapeutics Presents Data for its Chronic Hepatitis B Drug Candidates at the 30th Annual Conference of the Asian Pacific Association for the Study of the Liver
SOUTH SAN FRANCISCO, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS),…
Catalyst Biosciences Presents Pre-clinical SQ Treatment of Bleeds Data from its Marzeptacog alfa (activated) (MarzAA) Program at the 14th Annual EAHAD Congress
SOUTH SAN FRANCISCO, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO)…